Abstract:The tumor microbiome, a complex community of microbes found in tumors, has been found to be linked to cancer development, progression, and treatment outcome. However, it remains a bottleneck in distangling the relationship between the tumor microbiome and host gene expressions in tumor microenvironment, as well as their concert effects on patient survival. In this study, we aimed to decode this complex relationship by developing ASD-cancer (autoencoder-based subtypes detector for cancer), a semi-supervised deep learning framework that could extract survival-related features from tumor microbiome and transcriptome data, and identify patients' survival subtypes. By using tissue samples from The Cancer Genome Atlas database, we identified two statistically distinct survival subtypes across all 20 types of cancer Our framework provided improved risk stratification (e.g., for liver hepatocellular carcinoma, [LIHC], log-rank test, P = 8.12E-6) compared to PCA (e.g., for LIHC, log-rank test, P = 0.87), predicted survival subtypes accurately, and identified biomarkers for survival subtypes. Additionally, we identified potential interactions between microbes and host genes that may play roles in survival. For instance, in LIHC, Arcobacter, Methylocella, and Isoptericola may regulate host survival through interactions with host genes enriched in the HIF-1 signaling pathway, indicating these species as potential therapy targets. Further experiments on validation data sets have also supported these patterns. Collectively, ASD-cancer has enabled accurate survival subtyping and biomarker discovery, which could facilitate personalized treatment for broad-spectrum types of cancers.IMPORTANCEUnraveling the intricate relationship between the tumor microbiome, host gene expressions, and their collective impact on cancer outcomes is paramount for advancing personalized treatment strategies. Our study introduces ASD-cancer, a cutting-edge autoencoder-based subtype detector. ASD-cancer decodes the complexities within the tumor microenvironment, successfully identifying distinct survival subtypes across 20 cancer types. Its superior risk stratification, demonstrated by significant improvements over traditional methods like principal component analysis, holds promise for refining patient prognosis. Accurate survival subtype predictions, biomarker discovery, and insights into microbe-host gene interactions elevate ASD-cancer as a powerful tool for advancing precision medicine. These findings not only contribute to a deeper understanding of the tumor microenvironment but also open avenues for personalized interventions across diverse cancer types, underscoring the transformative potential of ASD-cancer in shaping the future of cancer care.

A Disease Network-Based Deep Learning Approach for Characterizing Melanoma.

Two-Stage Deep Neural Network Via Ensemble Learning for Melanoma Classification

Melanoma Classification in Dermoscopy Images via Ensemble Learning on Deep Neural Network

A deep learning approach based on multi-omics data integration to construct a risk stratification prediction model for skin cutaneous melanoma

Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy.

DeepTpNet: A Deep Learning Approach to Identify Cancer Subtypes Based on Multi-omics Data.

A novel deep learning framework for accurate melanoma diagnosis integrating imaging and genomic data for improved patient outcomes

A network-based deep learning methodology for stratification of tumor mutations

Deep Learning Based Tumor Type Classification Using Gene Expression Data

Graph deep learning for the characterization of tumour microenvironments from spatial protein profiles in tissue specimens

Deep Learning Enabled Integration of Tumor Microenvironment Microbial Profiles and Host Gene Expressions for Interpretable Survival Subtyping in Diverse Types of Cancers.

DeepGene: an Advanced Cancer Type Classifier Based on Deep Learning and Somatic Point Mutations

Bi-level Graph Learning Unveils Prognosis-Relevant Tumor Microenvironment Patterns in Breast Multiplexed Digital Pathology

Deep learning links localized digital pathology phenotypes with transcriptional subtype and patient outcome in glioblastoma

Genomic Pan-Cancer Classification Using Image-Based Deep Learning.

Deep learning classification of uveal melanoma based on histopathological images and identification of a novel indicator for prognosis of patients

Vital Characteristics Cellular Neural Network (VCeNN) for Melanoma Lesion Segmentation: A Biologically Inspired Deep Learning Approach

Deep Learning Model for Tumor Type Prediction using Targeted Clinical Genomic Sequencing Data

Integrative data analysis of multi-platform cancer data with a multimodal deep learning approach

Deep learning-based cancer survival prognosis from RNA-seq data: approaches and evaluations

Unravelling tumour cell diversity and prognostic signatures in cutaneous melanoma through machine learning analysis